Systematic analysis of bisphosphonate intervention on periprosthetic BMD as a function of stem design.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Arthroplasty

• Publication date

  2014-06-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/j.arth.2014.01.015PMID 24703781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ibandronate and cementless total hip arthroplasty: densitometric measurement of periprosthetic bone mass and new therapeutic approach to the prevention of aseptic loosening.

  2012cited by this paper
• Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 randomized controlled trials

  2012cited by this paper
• The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial.

  2011cited by this paper
• A systematic review assessing the effectiveness of alendronate in reducing periprosthetic bone loss after cementless primary THA.

  2011cited by this paper
• Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.

  2011cited by this paper
• A comparison of the effects of alendronate and alfacalcidol on bone mineral density around the femoral implant and in the lumbar spine after total hip arthroplasty.

  2011cited by this paper
• Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study

  2011cited by this paper
• Alendronate Reduces Periprosthetic Bone Loss after Uncemented Primary Total Hip Arthroplasty — A 5-Year Follow-up of 16 Patients

  2010cited by this paper
• Bisphosphonates treatment and orthodontic considerations.

  2010cited by this paper
• Long-term use of bisphosphonates in osteoporosis.

  2010cited by this paper
• Decreased Periprosthetic Bone Loss in Patients Treated with Clodronate: A 1-Year Randomized Controlled Study

  2010cited by this paper
• Female patients with low systemic BMD are prone to bone loss in Gruen zone 7 after cementless total hip arthroplasty

  2009cited by this paper
• Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty

  2009cited by this paper
• Alendronate inhibits periprosthetic bone loss around uncemented femoral components

  2007cited by this paper
• Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty

  2007cited by this paper
• Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: Prospective randomized double‐blind study

  2006cited by this paper
• Effect of etidronate in preventing periprosthetic bone loss following cemented hip arthroplasty: A randomized, double blind, controlled trial

  2006cited by this paper
• Clinical and radiological outcome of total hip replacement five years after pamidronate therapy. A trial extension.

  2006cited by this paper
• Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomised study.

  2006cited by this paper
• Biomechanics and preclinical testing of artificial joints : the hip

  2005cited by this paper
• Etidronate does not suppress periprosthetic bone loss following cemented hip arthroplasty

  2005cited by this paper
• Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: A randomized trial

  2005cited by this paper
• Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis.

  2005cited by this paper
• Efficacy of different dosing schedules of etidronate for stress shielding after cementless total hip arthroplasty

  2005cited by this paper
• Basic orthopaedic biomechanics and mechano-biology

  2005cited by this paper
• Changes in bone mineral density in the proximal femur after cementless total hip arthroplasty. A five-year longitudinal study.

  2004cited by this paper
• Effects of discontinuation as well as intervention of cyclic therapy with etidronate on bone remodeling after cementless total hip arthroplasty.

  2004cited by this paper
• Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty.

  2003cited by this paper
• Dosisabhängige Prophylaxe des frühen periprothetischen Knochenschwundes durch Alendronat

  2002cited by this paper
• [Dose-dependent prevention of early periprosthetic bone loss by alendronate].

  2002cited by this paper
• Alendronate Reduces Periprosthetic Bone Loss After Uncemented Primary Total Hip Arthroplasty: A Prospective Randomized Study

  2001cited by this paper
• Periprosthetic bone mineral density changes with femoral components of differing design philosophy

  2001cited by this paper
• Effect of Pamidronate in Preventing Local Bone Loss After Total Hip Arthroplasty: A Randomized, Double‐Blind, Controlled Trial

  2001cited by this paper
• The prevention of periprosthetic fractures in total hip and knee arthroplasty.

  1999cited by this paper
• Femoral bone loss in total knee arthroplasty. A review.

  1999cited by this paper
• Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis.

  1996cited by this paper
• Increased osteoclastic differentiation by PMMA particle-associated macrophages. Inhibitory effect by interleukin 4 and leukemia inhibitory factor.

  1996cited by this paper
• Oral alendronate induces progressive increases in bone mass of the spine, hip and total body over 3 years in postmenopausal women with osteoporosis

  1996cited by this paper
• A prospective study of proximal femur bone mass following cemented and uncemented hip arthroplasty

  1996cited by this paper
• Femoral Bone Loss Following Hip Replacement: A Comparative Study

  1995cited by this paper
• Fit of the uncemented femoral component and the use of cement influence the strain transfer to the femoral cortex

  1994cited by this paper

• Determining the most effective osteoporosis drug for bone mineral density loss in proximal area after total hip arthroplasty: A network meta-analysis

  2025cites this paper
• Risikofaktoren und Präventionsstrategien periprothetischer Femurfrakturen in der Hüftendoprothetik

  2024cites this paper
• Bisphosphonates’ use and risk of aseptic loosening following total hip arthroplasty: a systematic review

  2023cites this paper
• Bisphosphonate Use may be Associated with an Increased Risk of Periprosthetic Hip Fracture.

  2023cites this paper
• Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty

  2022cites this paper
• Efficacy of Alendronate in Preventing Periprosthetic Bone Loss after Implantation of a Primary Hip Endoprosthesis

  2022cites this paper
• Intra-operative Clodronate Rinsing Improves the Integration of the Femoral Stem in a Prospective, Double-blinded, Randomized, Placebo-controlled Clinical RSA-study

  2021cites this paper
• Experimental study of the effects of hypoxia simulator on osteointegration of titanium prosthesis in osteoporotic rats

  2021cites this paper
• Preoperative factors predicting the severity of BMD loss around the implant after Total hip Arthroplasty

  2021cites this paper
• Total hip arthroplasty in patients with osteoporosis

  2020cites this paper
• Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up: a randomized controlled trial

  2020cites this paper
• Influence of Hydroxyapatite Coating for the Prevention of Bone Mineral Density Loss and Bone Metabolism after Total Hip Arthroplasty: Assessment Using 18F-Fluoride Positron Emission Tomography and Dual-Energy X-Ray Absorptiometry by Randomized Controlled Trial

  2020influential citation
• Bone remodelling and integration of two different types of short stem: a dual-energy X-ray – absorptiometry study

  2020cites this paper
• The use of bisphosphonates to meet orthopaedic challenges.

  2020cites this paper
• Biomechanics of Implant Fixation in Osteoporotic Bone

  2020cites this paper
• RADIOSTEREOMETRIC ANALYSIS OF INITIAL FEMORAL STEM MIGRATION IN CEMENTLESS TOTAL HIP ARTHROPLASTY OF POSTMENOPAUSAL WOMEN

  2020influential citation
• Peri-prosthetic bone remodeling and change in bone mineral density in the femur after cemented polished tapered stem implantation

  2019cites this paper
• Preoperative Morphology of the Proximal Femoral Canal Did Not Affect the Postoperative Bone Mineral Density Change Around the Zweymüller-Type Stem.

  2019cites this paper
• Zoledronate induces cell cycle arrest and differentiation by upregulating p21 in mouse MC3T3-E1 preosteoblasts

  2019cites this paper
• Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis

  2019cites this paper
• Effects of bisphosphonates in preventing periprosthetic bone loss following total hip arthroplasty: a systematic review and meta-analysis

  2018cites this paper
• Restoration of proximal periprosthetic bone loss by denosumab in cementless total hip arthroplasty

  2018cites this paper
• Periprosthetic Femoral Bone Loss in Total Hip Arthroplasty: Systematic Analysis of the Effect of Stem Design

  2017cites this paper
• Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty: A meta-analysis from randomized controlled trails.

  2017cites this paper
• Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial

  2017cites this paper
• Densitometric evaluation of bone-prosthetic counterface in hip and knee arthroplasty with modern implants.

  2016cites this paper
• Teriparatide Versus Alendronate for the Preservation of Bone Mineral Density After Total Hip Arthroplasty - A randomized Controlled Trial.

  2016cites this paper
• Effects of teriparatide on cementless bipolar hemiarthroplasty in patients with osteoporotic femoral neck fractures

  2016cites this paper
• Results of total hip arthroplasty using a bionic hip stem

  2015cites this paper
• Bone Remodelling in the Proximal Femur after Uncemented Total Hip Arthroplasty in Patients with Osteoporosis

  2015cites this paper
• [Bone Remodelling in the Proximal Femur after Uncemented Total Hip Arthroplasty in Patients with Osteoporosis].

  2015cites this paper